Private company

Consonance Capital Management LP

Limited partnership registered in the United States, active since 2007. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersNew York, United States²
Legal formLimited Partnership²
Kind of organizationLimited partnership²
LEI549300UFH280DE39TF17²
StatusActive²
LEI statusIssued and current²
Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
Registered withDivision of Corporations, Department of State, 4288837²

See how the biggest companies compare on our leaderboards

Corporate structure

Consonance Capital Management LP sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Consonance Capital Management LP New York, New York, United States
- ADMA Biologics (United States) Stake · Ramsey
- ASSEMBLY BIOSCIENCES, INC. Stake · Wilmington, Delaware, United States
- CASI Pharmaceuticals, Inc (DE) Stake · Rockville, Maryland
- Cellectar Biosciences, Inc. Stake · Madison, Wisconsin, United States
- Gamida Cell Ltd. Stake · L3
- Protagonist Therapeutics, Inc Stake · Newark, California
- Sio Gene Therapies Inc. Stake · New York, New York
- Surrozen, Inc./DE Stake · South San Francisco, California

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Timeline

Jan 22, 2007Founded Consonance Capital Management LP is founded²

Filings

5 filings to the SEC since October 2021: 5 other. The latest 5:

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Consonance Capital Management LP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

Surrozen, Inc./DESC 13D/A Dec 15, 2022³
ADMA Biologics (United States)SC 13G/A Feb 14, 2022⁴
ASSEMBLY BIOSCIENCES, INC.SC 13G/A Feb 14, 2022⁵
CASI Pharmaceuticals, Inc (DE)SC 13G/A Feb 14, 2022⁶
Cellectar Biosciences, Inc.SC 13G/A Feb 14, 2022⁷
Gamida Cell Ltd.SC 13G/A Feb 14, 2022⁸
Protagonist Therapeutics, IncSC 13G/A Feb 14, 2022⁹
Sio Gene Therapies Inc.SC 13G/A Feb 14, 2022¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARConsonance Capital Management LP filings on SEC EDGAR
2
GLEIFConsonance Capital Management LP LEI record (549300UFH280DE39TF17)
3
SEC EDGARConsonance Capital Management LP SC 13D/A on Surrozen, Inc./DE
4
SEC EDGARConsonance Capital Management LP SC 13G/A on ADMA Biologics (United States)
5
SEC EDGARConsonance Capital Management LP SC 13G/A on ASSEMBLY BIOSCIENCES, INC.
6
SEC EDGARConsonance Capital Management LP SC 13G/A on CASI Pharmaceuticals, Inc (DE)
7
SEC EDGARConsonance Capital Management LP SC 13G/A on Cellectar Biosciences, Inc.
8
SEC EDGARConsonance Capital Management LP SC 13G/A on Gamida Cell Ltd.
9
SEC EDGARConsonance Capital Management LP SC 13G/A on Protagonist Therapeutics, Inc
10
SEC EDGARConsonance Capital Management LP SC 13G/A on Sio Gene Therapies Inc.